Submitted by Anonymous on Thu, 14/02/2013 - 05:07.
Too many years, too many promises with nothing to show. The company was never able to get its act together and went chasing after genomic rainbows instead of proteins, where they could have really shined.
The stock was down by about
The stock was down by about 30%. What next?
Too many years, too many
Too many years, too many promises with nothing to show. The company was never able to get its act together and went chasing after genomic rainbows instead of proteins, where they could have really shined.
What changes have happened an
What changes have happened an what (changes) are going to happen?
It seems he has retired.
It seems he has retired. They have changed the CEO and board members.
Is the company going to be sold? What happened?
Post new comment